NCT03761498

Brief Summary

This study evaluates the relationship between growth and stool microbiota in premature infants.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
118

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 29, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 3, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

July 15, 2019

Completed
6.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

April 1, 2025

Status Verified

March 1, 2025

Enrollment Period

6.5 years

First QC Date

November 29, 2018

Last Update Submit

March 26, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • quantitative rT-PCR of stool microbiome

    alpha diversity of bacterial groups in normal growth vs. poor growth

    8-10 weeks depending on length of stay in NICU

Study Arms (2)

Normal Growth

Require less than or equal to 110 kcal/kg/day to maintain growth curve

Slow Growth

Require more than 110 kcal/kg/day to maintain growth curve

Other: Caloric Requirement

Interventions

Infants will be provided standard of care and given calories required to maintain appropriate growth per unit policies already in place.

Slow Growth

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Preterm infants born at less than 28 weeks gestation will be eligible from birth until discharge. Infants with major congenital anomalies which alter growth patterns will be excluded.

You may qualify if:

  • All infants less than 28 weeks gestation who are admitted to the Parkland Hospital NICU.

You may not qualify if:

  • Infants \>27 weeks gestation. Infants with major congenital anomalies which may alter growth patterns.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Parkland Hopsital and Health System

Dallas, Texas, 75235, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Stool samples

MeSH Terms

Conditions

Growth DisordersFailure to ThrivePremature Birth

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Pediatrics

Study Record Dates

First Submitted

November 29, 2018

First Posted

December 3, 2018

Study Start

July 15, 2019

Primary Completion

December 30, 2025

Study Completion

December 30, 2025

Last Updated

April 1, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations